These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 1646001)

  • 21. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.
    Hsiang YH; Hertzberg R; Hecht S; Liu LF
    J Biol Chem; 1985 Nov; 260(27):14873-8. PubMed ID: 2997227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered topoisomerase I activity and recombination activating gene expression in a human leukemia cell line resistant to doxorubicin.
    Riou JF; Grondard L; Petitgenet O; Abitbol M; Lavelle F
    Biochem Pharmacol; 1993 Sep; 46(5):851-61. PubMed ID: 8396937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol.
    Adlakha RC; Ashorn CL; Chan D; Zwelling LA
    Cancer Res; 1989 Apr; 49(8):2052-8. PubMed ID: 2539251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.
    Nelson EM; Tewey KM; Liu LF
    Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1361-5. PubMed ID: 6324188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of a heat-stable topoisomerase II-DNA cleavable complex by nonintercalative terpenoides, terpentecin and clerocidin.
    Kawada S; Yamashita Y; Fujii N; Nakano H
    Cancer Res; 1991 Jun; 51(11):2922-5. PubMed ID: 1851667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase.
    Lefevre D; Riou JF; Ahomadegbe JC; Zhou DY; Benard J; Riou G
    Biochem Pharmacol; 1991 Jun; 41(12):1967-79. PubMed ID: 1645555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stabilization of the topoisomerase II-DNA cleavage complex by antineoplastic drugs: inhibition of enzyme-mediated DNA religation by 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Robinson MJ; Osheroff N
    Biochemistry; 1990 Mar; 29(10):2511-5. PubMed ID: 2159323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II.
    Wassermann K; Markovits J; Jaxel C; Capranico G; Kohn KW; Pommier Y
    Mol Pharmacol; 1990 Jul; 38(1):38-45. PubMed ID: 2164630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel selective inhibitors for human topoisomerase I, BM2419-1 and -2 derived from saintopin.
    Ishiyama D; Futamata K; Futamata M; Kasuya O; Kamo S; Yamashita F; Kanazawa S
    J Antibiot (Tokyo); 1998 Dec; 51(12):1069-74. PubMed ID: 10048564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of cell proliferation and chromatin conformation on intercalator-induced, protein-associated DNA cleavage in human brain tumor cells and human fibroblasts.
    Zwelling LA; Estey E; Silberman L; Doyle S; Hittelman W
    Cancer Res; 1987 Jan; 47(1):251-7. PubMed ID: 3024817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proliferation dependence of topoisomerase II mediated drug action.
    Sullivan DM; Glisson BS; Hodges PK; Smallwood-Kentro S; Ross WE
    Biochemistry; 1986 Apr; 25(8):2248-56. PubMed ID: 3011082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
    Ling YH; Andersson BS; Nelson JA
    Cancer Biochem Biophys; 1990 Jan; 11(1):23-30. PubMed ID: 2159843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
    Lanza A; Tornaletti S; Stefanini M; Evans HH; Ricanati M; Astaldi Ricotti GC; Pedrini AM
    Carcinogenesis; 1993 Sep; 14(9):1759-63. PubMed ID: 8403196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
    de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
    Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Saintopin, a dual inhibitor of DNA topoisomerases I and II, as a probe for drug-enzyme interactions.
    Leteurtre F; Fujimori A; Tanizawa A; Chhabra A; Mazumder A; Kohlhagen G; Nakano H; Pommier Y
    J Biol Chem; 1994 Nov; 269(46):28702-7. PubMed ID: 7961822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II.
    Rowe TC; Chen GL; Hsiang YH; Liu LF
    Cancer Res; 1986 Apr; 46(4 Pt 2):2021-6. PubMed ID: 3004716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Saintopin, a new antitumor antibiotic with topoisomerase II dependent DNA cleavage activity, from Paecilomyces.
    Yamashita Y; Saitoh Y; Ando K; Takahashi K; Ohno H; Nakano H
    J Antibiot (Tokyo); 1990 Oct; 43(10):1344-6. PubMed ID: 2175304
    [No Abstract]   [Full Text] [Related]  

  • 38. Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage.
    Andrea JE; Adachi K; Morgan AR
    Mol Pharmacol; 1991 Oct; 40(4):495-501. PubMed ID: 1656189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA).
    Bakic M; Beran M; Andersson BS; Silberman L; Estey E; Zwelling LA
    Biochem Biophys Res Commun; 1986 Jan; 134(2):638-45. PubMed ID: 3004458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs.
    Epstein RJ; Smith PJ
    Cancer Res; 1988 Jan; 48(2):297-303. PubMed ID: 2825970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.